Protecting America’s Medical Supply Chains Act of 2026

This bill would amend the Defense Production Act of 1950 to state that its powers should be used when appropriate to ensure the supply of medical materials, such as drugs, devices, and biological products, that are essential to national defense. Within 180 days, the President would have to send certain members of Congress a strategy on securing medical supply chains, including an analysis of weak points and a timeline to keep key parts of the supply chain from being under the exclusive control of a foreign government. The President would also send yearly progress reports until September 30, 2029. The bill would let the President make payments to U.S.-based companies that produce critical components, technology, or materials to increase supply chain security, after certifying to Congress at least 30 days in advance that the payment is critical to national defense.

Full text and official record on Congress.gov

Sponsors

• Maria Elvira Salazar Republican sponsor
• 0 cosponsors